Non-steroidal anti-inflammatory treatment in cancer cachexia: A systematic literature review

By Solheim Tora S.  

Acta Oncologica, Vol. 52, Iss. 1, 2013-01 ,pp. : 6-17

Informa Healthcare

Access to resources Recommend Favorite

Drug interactions between the proteasome inhibitor bortezomib and cytotoxic chemotherapy, tumor necrosis factor (TNF), and TNF-related apoptosis-inducing ligand (TRAIL) in prostate cancer - An J, Sun Y-P, Adams J, Fisher M, Belldegrun A, Rettig MB, Veterans Administration Greater Los Angeles Healthcare System, Los Angeles, CA [J An, Y-PS, MF, MBR]; Millennium Pharmaceuticals, Inc., Cambridge, MA [J Adams]; and University of California at Los Angeles School of Medicine, Los Angeles, CA [AB, MBR].

By Chatta G.  

Urologic Oncology: Seminars and Original Investigations, Vol. 21, Iss. 6, 2003-11 ,pp. : 490-491

Elsevier

Access to resources Recommend Favorite

Non-steroidal anti-inflammatory drug and aspirin use and the risk of head and neck cancer: a systematic review

By Wilson Jessica  

Cancer Causes and Control, Vol. 22, Iss. 5, 2011-05 ,pp. : 803-810

Springer Publishing Company

Access to resources Recommend Favorite

Combination Treatment for Glioblastoma Cells with Tumor Necrosis Factor-Related Apoptosis-Inducing Ligand and Oncolytic Adenovirus Delta-24

By Tsamis Konstantinos I.   Alexiou George A.   Vartholomatos Evrysthenis   Kyritsis Athanasios P.  

Cancer Investigation, Vol. 31, Iss. 9, 2013-11 ,pp. : 630-638

Informa Healthcare

Access to resources Recommend Favorite

Inhibition of p38 mitogen-activated protein kinase potentiates the apoptotic effect of berberine/tumor necrosis factor-related apoptosis-inducing ligand combination therapy

By        

Oncology Letters, Vol. 10, Iss. 3, 2015-01 ,pp. : 1907-1911

Spandidos Publications

Access to resources Recommend Favorite